Effectiveness and safety of Apixaban versus warfarin in obese patients with Nonvalvular atrial fibrillation enrolled in Medicare and veteran affairs
S Deitelzweig, J Sah, A Kang, C Russ, M Preib… - The American Journal of …, 2022 - Elsevier
Real-world studies have evaluated the use of anticoagulants in obese patients with
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs.
S Deitelzweig, J Sah, A Kang, C Russ… - The American Journal …, 2022 - europepmc.org
Real-world studies have evaluated the use of anticoagulants in obese patients with
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
[引用][C] Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs
S Deitelzweig, J Sah, A Kang, C Russ… - American Journal …, 2022 - espace.library.uq.edu.au
Real-world studies have evaluated the use of anticoagulants in obese patients with
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs
S Deitelzweig, J Sah, A Kang… - The American …, 2022 - pubmed.ncbi.nlm.nih.gov
Real-world studies have evaluated the use of anticoagulants in obese patients with
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs
S Deitelzweig, J Sah, A Kang, C Russ… - American Journal of …, 2022 - ajconline.org
Real-world studies have evaluated the use of anticoagulants in obese patients with
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs
S Deitelzweig, J Sah, A Kang, C Russ… - … American Journal of …, 2022 - search.proquest.com
Real-world studies have evaluated the use of anticoagulants in obese patients with
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …
nonvalvular atrial fibrillation (NVAF), but they have been limited by sample size or the use of …